Buspirone enhances [3H]flunitrazepam binding in vivo

European Journal of Pharmacology

Volumn 87, Issue 4, 1983, Pages 499-500

  Oakley, N R ^a   Jones, B J ^a  

^a GLAXOSMITHKLINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BUSPIRONE; DIAZEPAM; FLUMAZENIL; RADIOISOTOPE; ANTI ANXIETY AGENTS; ANTI ANXIETY AGENTS, BENZODIAZEPINE; ANXIOLYTIC AGENT; DIAGNOSTIC AGENT; FLUNITRAZEPAM; PYRIMIDINE DERIVATIVE; TRITIUM;

ANIMAL EXPERIMENT; CENTRAL NERVOUS SYSTEM; DRUG POTENTIATION; DRUG RECEPTOR BINDING; FLUNITRAZEPAM H 3; NONHUMAN; PHARMACOKINETICS; RAT; ANIMAL; ARTICLE; BRAIN; MALE; METABOLISM;

ANIMAL; ANTI-ANXIETY AGENTS; ANTI-ANXIETY AGENTS, BENZODIAZEPINE; BRAIN; BUSPIRONE; FLUNITRAZEPAM; MALE; PYRIMIDINES; RATS; TRITIUM;

EID: 0020645630     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/0014-2999(83)90093-6     Document Type: Article

References (3)

1. Buspirone: effects on central monoaminergic transmission - possible relevance to animal experimental and clinical findings
2. Buspirone - an anxioselective drug with dopaminergic action
3. A simple and reliable conflict procedure for testing anti-anxiety agents